Acurx Pharmaceuticals Advances To Phase 3 Trials For C. Difficile Infection, Stock Down
24/2 19:48
(RTTNews) - Acurx Pharmaceuticals, Inc. (ACXP) Monday announced that its lead antibiotic candidate, ibezapolstat, is advancing to international Phase 3 clinical trials for treating C. difficile Infection....